DROSPIRENON/ETHINYLESTRADIOL WH-PHARMA
3MG/0,02MG TBL FLM 3X28(21+7)
SÚKL code | 0220761 |
---|---|
Name of the product | DROSPIRENON/ETHINYLESTRADIOL WH-PHARMA |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | DROSPIRENON/ETHINYLESTRADIOL WH-PHARMA |
Supplement | 3MG/0,02MG TBL FLM 3X28(21+7) |
Strenght | 3MG/0,02MG |
Pharmaceutical form | Film-coated tablet |
Package | 3X28(21+7) |
Route | Oral use |
Language of the pack | Czech |
Wrap type | Blister |
Legal status | na lékařský předpis |
Active substance |
ETHINYLESTRADIOL (ETHINYLESTRADIOLUM) DROSPIRENONE (DROSPIRENONUM) |
ATC group | G03AA12 |
ATC group name | DROSPIRENON A ETHINYLESTRADIOL |
Marketing authorisation information
Registration Number | 17/1046/16-C |
---|---|
Type of MA | National |
MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
Placed on the market till | 31. 01. 2020 |
MA Holder | WH-Pharma s.r.o., Kutná Hora |
MA Holder country | ČESKÁ REPUBLIKA |
Actual MA holder | Aristo Pharma GmbH, Berlin |
Actual MA holder country | NĚMECKO |